IceCure Medical Ltd. ICCM 深 滬
已收盤 02-06 16:00:00 美东时间
0.59
+0.039
+7.04%
華盛通- 最 高0.60
- 今 開0.564
- 成交量 13.32万股
- 最 低 0.564
- 昨 收 0.5512
- 總市值 4068.83万
- 52周最高 1.6288
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 0.5401
- 委 比 20.48%
- 總股本 6896.32万
- 歷史最高 12.167
- 量 比 0.57
- 振 幅 6.53%
- 歷史最低 0.471
- 每 手 1
- 風險率 0.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多IceCure Medical Reports ProSense Sales Of ~$3.4M For 2025, Provides 2025 Highlights, 2026 Milestones
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today
01-12 21:40
IceCure Medical Expects To Report Higher Q4 Sales In North America Compared To Last Year
ProSense® systems are being sold and installed at new locations across North America, including some of the most highly regarded medical institutions in the United StatesCAESAREA, Israel, Dec. 17, 2025 /PRNewswire/
2025-12-17 21:46
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 18.6% to $2.1...
2025-11-21 05:06
Icecure Medical Q3 EPS $0.06 Beats $(0.05) Estimate, Sales $850.000K Beat $714.000K Estimate
Icecure Medical (NASDAQ:ICCM) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.05) by 220 percent. This is a 175 percent increase over losses of $(0.08) per share from the
2025-11-19 22:08
Earnings Scheduled For November 19, 2025
Companies Reporting Before The Bell • Lowe's Companies (NYSE:LOW) is expected t...
2025-11-19 19:11
IceCure Medical Receives Registration, Approval For Its ProSense System For Distribution By Swissmedic
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today
2025-11-18 21:45
IceCure Medical Promotes Shay Levav To COO, As Company Expands Commercial Activities In U.S. Following FDA Marketing Clearance For ProSense
Mr. Levav's appointment ensures seamless and focused organizational structure as Company expands commercial activities in the U.S. following FDA marketing clearance for ProSense®CAESAREA, Israel, Nov. 10, 2025
2025-11-10 21:42
IceCure Medical Announces Termination of VP of Operations
Icecure Medical ( ($ICCM) ) has issued an update. On October 16, 2025, IceCure ...
2025-10-17 20:29
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
2025-10-08 09:14
IceCure Medical’s ProSense® Receives FDA Approval for Breast Cancer Treatment
An update from Icecure Medical ( ($ICCM) ) is now available. On October 3, 2025...
2025-10-04 04:29
